Most viewed |
Popular cholesterol drug may hurt, not help A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. |
Top rated |
Pfizer drug studies fudged, report says Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often fudged, indicating the medicine worked better than internal company documents showed. |
Most e-mailed |
Omega-3 deficiency may be hurting our hearts A growing body of scientific literature touts the benefits of omega-3 supplementation. Studies show that these special fatty acids accumulate in the brain and can aid children with learning disabilities, reduce violence in prison, and even improve everyday mood. |
 | Most viewed videos |
 TODAY Chimp attack victim breaks her silence Nov. 12: Charla Nash, the woman who was brutally mauled by her friend’s pet chimpanzee, speaks out for the first time and bravely shows the extent of her injuries. NBC’s Jeff Rossen reports. |
Sponsored links
Resource guide
Hotmail
Top slideshows
